Overview

A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia

Status:
Completed
Trial end date:
2008-08-19
Target enrollment:
Participant gender:
Summary
To evaluate the safety of the long-term use of pregabalin.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin